Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06410144 · ClinicalTrials.gov registry record · NA
Chronic Kidney Disease-Education (CKD-EDU)
A NA study of Chronic Kidney Diseases, sponsored by University of Rochester.
- Recruiting
- Registry status
- NA
- Development phase
- 326
- Enrollment target
- 5
- Study locations
NCT06410144: Recruiting NA study of Chronic Kidney Diseases, sponsored by University of Rochester.
NCT06410144 is a NA study of Chronic Kidney Diseases that is actively recruiting participants, run by University of Rochester. The registered enrollment target is 326 participants, below the 440-participant average among 73 other Chronic Kidney Diseases trials with a reported enrollment target (26% lower). The trial reports 5 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06410144, a NA study of Chronic Kidney Diseases, is actively recruiting participants, sponsored by University of Rochester.
- RECRUITING
- Registry status
- NA
- Development phase
- 326 participants
- Enrollment target
- 5
- Study locations
Study Summary
The investigators are conducting a study to see which program better helps older patients with kidney disease choose their treatment. Investigators are also investigating if either program can reduce the number of hospital or emergency room visits in the first 6 months of the study, as well as potentially improve end-of-life care for older adults. Half of the participants will receive Program A, while the other half will receive Program B. Investigators will compare the two groups to see which participants feel better prepared about their kidney therapy decisions, experience improved end-of-life care, and have fewer emergency room visits and hospital admissions. Participants in Program A will receive information from the National Kidney Foundation and meet with a kidney therapy educator. Participants in Program B will get information about kidney disease treatment and meet with a decision-support specialist who's an expert in decision-making.
Primary Outcome
Determine whether the intervention improves kidney therapy decision-making at 12 weeks by using the Decisional Conflict Scale. Score ranges from 0-100. Lower scores indicate better outcomes.
Conditions Studied
Interventions
- BEHAVIORAL Program A
- BEHAVIORAL Program B
Study Locations (5)
New York
- UR Medicine Nephrology - Strong West - Brockport
- Nephrology Clinic - Thompson Professional Building - Canandaigua
- Nephrology Clinic - St. James Medical Office Building - Hornell
- Highland Hospital - Rochester
- University of Rochester Medical Center - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 326 participants |
| Start Date | 2025-02-27 |
| Est. Completion | 2029-05 |
| Phase | NA |
What NCT06410144 shows while recruiting
NCT06410144 is an interventional study that assigns participants to a tested intervention. The registered 326 participants enrollment target is mid-sized for trials with a published cap, below the 440-participant average among 73 other Chronic Kidney Diseases trials with a reported enrollment target (26% lower).
The record links to 1 condition, with Chronic Kidney Diseases appearing as the primary indexed condition, and to 2 interventions - of which Program A is the first listed.
NCT06410144 lists 5 locations in 1 state (New York).
Frequently Asked Questions
What is clinical trial NCT06410144 about?
NCT06410144 is a clinical study titled "Chronic Kidney Disease-Education (CKD-EDU)". The investigators are conducting a study to see which program better helps older patients with kidney disease choose their treatment. Investigators are also investigating if either program can reduce the number of hospital or emergency room visits in the first 6 months of the study, as well as poten...
What is the current status of trial NCT06410144?
This trial is currently recruiting. It is a NA study. The enrollment target is 326 participants. The study started on 2025-02-27. Estimated completion is 2029-05.
What conditions does trial NCT06410144 study?
This clinical trial studies the following conditions: Chronic Kidney Diseases.
What interventions are being tested in trial NCT06410144?
The interventions under investigation include: Program A (BEHAVIORAL), Program B (BEHAVIORAL).
Who is sponsoring clinical trial NCT06410144?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06410144 being conducted?
This trial has 5 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Kidney Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06410144's enrollment target sits among peer trials
326 22nd of 73 higher than 52 of 73 other Chronic Kidney Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Kidney Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
RECRUITING · NA
-
Mindfulness in Chronic Kidney Disease
RECRUITING · NA
-
Home Hospital for Suddenly Ill Adults
RECRUITING · NA
-
Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
RECRUITING · NA
-
Improving the Collaborative Health of Minority COVID-19 Survivor and Carepartner Dyads
RECRUITING · NA
-
Handgrip Exercise Training and CKD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06586619 · 326 participants · NA
A Remotely Delivered Tai Chi/Qigong Intervention for Older People Living With HIV
- NCT07040566 · 326 participants · Phase 2
A Trial of Varenicline for E-cigarette Cessation
- NCT07165860 · 326 participants · NA
Clinical Trial to Reduce Perinatal Intimate Partner Violence
- NCT04486378 · 327 participants · Phase 2
A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI